NCT03497624View on ClinicalTrials.gov

ALCMI-006: A Prospective Biospecimen Collection Study From Patients With ROS1-Fusion Positive Tumors

CompletedOBSERVATIONAL
Enrollment

5

Participants

Timeline

Start Date

April 23, 2018

Primary Completion Date

September 4, 2020

Study Completion Date

September 4, 2020

Conditions
ROS1-fusion Positive Tumor
Interventions
OTHER

Biospecimens collection

Collection of tumor tissue when a participant is having a clinically-indicated biopsy or surgery for their ROS1-fusion cancer.

Trial Locations (1)

94040

ALCMI, San Carlos

All Listed Sponsors
lead

Addario Lung Cancer Medical Institute

OTHER

NCT03497624 - ALCMI-006: A Prospective Biospecimen Collection Study From Patients With ROS1-Fusion Positive Tumors | Biotech Hunter | Biotech Hunter